News | June 12, 2014

Philips Highlights Vereos Digital PET/CT at SNMMI

First digital PET/CT scanner joins suite of molecular imaging solutions

June 12, 2014 — Philips Healthcare recently introduced Vereos PET/CT, the first digital PET/CT (positron emission tomography/computed tomography) scanner, at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) in St. Louis. In addition to Vereos, Philips showcased a selection of molecular imaging solutions designed to deliver high image quality, critical clinical information and greater connectivity.

The Vereos PET/CT uses digital silicon photomultiplier detectors instead of traditional analog detectors, creating a step change in performance that includes approximately two-times increase in sensitivity gain, volumetric resolution and quantitative accuracy compared to analog systems. These improvements can ultimately be translated into high image quality, increased diagnostic confidence, improved treatment planning and faster workflows.

"From connected devices to data-driven insights, the pace of imaging innovation is allowing us to see more," said Gene Saragnese, chief executive officer, Imaging Systems, Philips. "Molecular imaging technology is leading the way with digital detection and advanced visualization built on insights from those at the heart of care."

Visitors to the Philips booth at SNMMI had the opportunity to interact with Vereos digital PET/CT clinical images and technology using engaging 3-D visualization tools. The experience provided clinicians an understanding of how Vereos can be used to deliver customized care to meet their most pressing needs.

During the SNMMI annual meeting, Philips also hosted a series of three "Innovation Talks" in its booth theater area, spotlighting customers, scientists and industry thought leaders who discussed topics related to the current and future landscape for digital PET, patient-centered imaging and the importance of creating customized workflows to help manage patient care and radiation dose.

Other advanced molecular imaging technology solutions showcased include”

  • iPatient: An advanced platform with an intuitive interface, iPatient helps to facilitate patient-centered imaging, allows for efficient communication between the CT system and injector, and aids in the delivery of appropriate contrast dose and consistent image quality.
  • BrightView XCT: A SPECT/CT system designed entirely for nuclear medicine, BrightView XCT enables low patient dose levels, high-resolution localization and high-quality attenuation correction, for smart assessments and short exams with the patient's comfort in mind.
  • IntelliSpace Portal: Part of Philips' family of clinical information systems within Philips Healthcare’s Informatics Solutions and Services Group, the IntelliSpace Portal offers extensive clinical coverage, streamlined workflow and continuous evolution of advanced visualization and analysis capabilities within a single solution.


For more information: www.philips.com/snmmi

Related Content

Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Nuclear myocardial perfusion scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers. The image shows good clarity with delineation of the left ventricular edge and papillary muscles without cardiac gating.

Nuclear myocardial perfusion scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers. The image shows good clarity with delineation of the left ventricular edge and papillary muscles without cardiac gating.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
New PET-CT Scan Improves Detection in Rare Cardiac Condition
News | PET-CT | July 25, 2017
Using a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests,...
PET/CT, calcium blockages, heart attack risk, Intermountain study, American Heart Association, AHA Scientific Sessions 2016
News | PET-CT | November 15, 2016
Many people who experience chest pain but don’t have a heart attack breathe a big sigh of relief when a stress test...
PET/CT, atherosclerotic plaque detection, Stanford University

Application of dual-modality optical and PET/CT activity-based probe in experimental carotid inflammation model. Coronal noninvasive PET/CT scans of (A) healthy and (B) diseased mice with and without ligated carotid arteries respectively. Inset images show optical ex vivo florescence imagining of (A) healthy and (B) diseased carotid arteries.  PET/CT and optical images courtesy of Xiaowei Ma, Toshinobu Saito and Nimali Withana.

News | PET-CT | November 01, 2016
Researchers at Stanford University have demonstrated for the first time the use of a dual optical and positron emission...
GE Healthcare, Discovery MI PET/CT system, FDA clearance, RSNA 2016
Technology | PET-CT | October 05, 2016
GE Healthcare recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Discovery MI digital...
PET/CT scan, brain stress center, heart disease predictor, ACC.16
News | PET-CT | April 05, 2016
New research shows individuals with a greater degree of activity in the stress center of the brain also have more...
Siemens, Biograph Horizon PET CT, FDA clearance
Technology | PET-CT | January 21, 2016
Siemens Healthcare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Biograph...
Toshiba, Celesteion, Steinberg Diagnostic Medical Imaging, U.S., first
News | PET-CT | June 08, 2015
Steinberg Diagnostic Medical Imaging (SDMI) of Las Vegas has bolstered its capabilities by installing the United...
Overlay Init